IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01061164|
Recruitment Status : Completed
First Posted : February 2, 2010
Last Update Posted : March 25, 2015
|Condition or disease|
The use of HAART has been important in extending the lives of people with HIV infection. However, prolonged use of HAART may have long-term consequences. In addition, people participating in clinical trials using experimental therapies to treat HIV infection may experience negative health outcomes. The purpose of this study is to identify the long-term effects of HIV infection, HAART, and experimental treatments in infants, children, and adolescents.
This study will enroll children who participated in PACTG 219C or various IMPAACT studies. There will be no study visits specifically for this study. Researchers will review participants' medical records annually and collect information on illnesses, medications, CD4 cell count and viral load data, and body measurements.
|Study Type :||Observational|
|Actual Enrollment :||1207 participants|
|Official Title:||A Prospective Surveillance Study of Long-Term Outcomes in HIV-Infected Infants, Children and Adolescents|
|Study Start Date :||March 2009|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2014|
HIV-infected infants, children, and adolescents
Infants, children, and adolescents with HIV infection who have participated in PACTG 219C and/or select IMPAACT studies.
- To identify possible long-term adverse outcomes of HIV infection and complications of antiretroviral therapy (ART) or experimental interventions other than ARTs in HIV-infected infants, children, and adolescents at IMPAACT sites in the United States [ Time Frame: Throughout the study ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01061164
Show 39 Study Locations
|Study Chair:||Myron J. Levin, MD||University of Colorado at Denver Health Sciences Center|
|Study Chair:||Paige L. Williams, PhD||Harvard School of Public Health|